The Effects of Hesperidin on Metabolic Syndrome

National Nutrition and Food Technology Institute

Status: Unknown

Conditions: Metabolic Syndrome

Treatments: Other: control; Dietary Supplement: hesperidin

Study type: Interventional

Funder types: Other

Identifiers

NCT03734874

6780

Details and patient eligibility

About

To study the effects of Hesperidin supplement in patients with metabolic syndrome, 50 patients will be randomly allocated to control group or 2 capsules Hesperidin for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age of 18 to 70 years
• having 3 of 5 of high blood sugar, hypertension, high TG, high waist circumference, low HDL

Exclusion criteria

• pregnancy or lactation
• A history of Cardiovascular disease, Pulmonary disease, Renal disease & Celiac disease; Cirrhosis
• Following program to lose weight in recent 3 mo

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups, including a placebo group

hesperidin

Active Comparator group

Treatment:

Dietary Supplement: hesperidin

control

Placebo Comparator group

Treatment:

Other: control